Bristol-Myers Squibb (NYSE:BMY)‘s stock had its “buy” rating restated by analysts at TheStreet in a research report issued to clients and investors on Thursday, Stock Ratings News reports. The analysts wrote, “Bristol-Myers Squibb Company (BMY) has been reiterated by TheStreet Ratings as a buy with a ratings score of B. The company’s strengths can be […]
Bristol-Myers Squibb Rating Reiterated by TheStreet (BMY) is a post from: Zolmax
The post Bristol-Myers Squibb Rating Reiterated by TheStreet (BMY) appeared first on Zolmax.